Evidence map›Paper›PMID 41322664›Full record

ArticlePreventive medicine reports2025

"Well, if they exist, I ignore them": A focus group study of recall and reactions to cannabis health warnings by cannabis consumers in the United States.

Zachary B Massey, Chinomso Ibe, Michael A Smith, Erin A Vogel, James F Thrasher, David Hammond

Abstract read
In one paragraph

Article in Preventive medicine reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zachary B MasseyTSET Health Promotion Research Center, Stephenson Cancer Center, University of Oklahoma Health Campus, Oklahoma City, OK, USA.
Chinomso IbeHudson College of Public Health, University of Oklahoma Health Campus, Oklahoma City, OK, USA.
Michael A SmithTSET Health Promotion Research Center, Stephenson Cancer Center, University of Oklahoma Health Campus, Oklahoma City, OK, USA.
Erin A VogelTSET Health Promotion Research Center, Stephenson Cancer Center, University of Oklahoma Health Campus, Oklahoma City, OK, USA.
James F ThrasherDepartment of Health Promotion, Education and Behavior, University of South Carolina, Columbia, SC, USA.
David HammondSchool of Public Health Sciences, University of Waterloo, Waterloo, Ontario, CA.

Funding

Developing and Testing Warning Labels for Retail Cannabis ProductsK01DA057395 · NIDA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Zachary Massey · 2023 to 2026
$717k
NIDA NIH HHS K01 DA057395
6 · The paper itself

Abstract

Objective: This study used qualitative focus groups to examine how cannabis consumers in the United States (U.S.) recalled health warnings on products they used and reacted to hypothetical cannabis health warnings. Methods: We conducted 12 focus groups (February-March 2025) with 77 cannabis consumers (≥ 21, used cannabis in the past 30 days, and lived in a U.S. state where recreational cannabis use was legal). Participants (aged 22-68; Median = 42.0, Interquartile range = 22.0) described health warnings on cannabis products they used before providing reactions to hypothetical cannabis health warnings. Results: Participants reported being unaware of or choosing to ignore health warnings on cannabis products they used. When presented with hypothetical cannabis health warnings, many participants expressed disbelief about the accuracy of the health claims. Personal experience with cannabis harms was cited as a reason for believing or disbelieving the warnings. To improve warning effectiveness, participants requested sources be cited to support health claims and suggested using direct language and enhanced visuals. Conclusions: Cannabis consumers mostly reported not noticing current cannabis health warnings and discredited warnings they did notice. Results suggest cannabis consumers require more evidence supporting claims in health warnings, more explicit statements of harms, and inclusion of visual cues to reinforce harms.

Indexed as

CannabisCannabis health warningsCannabis labelingHealth communicationMarijuana

Identifiers

PMID41322664
PMCPMC12657602

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.